Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

被引:18
|
作者
Sidana, Surbhi [1 ]
Tandon, Nidhi [1 ]
Brady, Peter A. [2 ,3 ]
Grogan, Martha [2 ]
Gertz, Morie A. [1 ]
Dispenzieri, Angela [1 ]
Lin, Grace [2 ]
Dingli, David [1 ]
Buadi, Francis K. [1 ]
Lacy, Martha Q. [1 ]
Kapoor, Prashant [1 ]
Gonsalves, Wilson, I [1 ]
Muchtar, Eli [1 ]
Warsame, Rahma [1 ]
Kumar, Shaji K. [1 ]
Kourelis, Taxiarchis, V [1 ]
机构
[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
[3] Iowa Heart Ctr, Iowa City, IA USA
关键词
STEM-CELL TRANSPLANTATION; CARDIAC AMYLOIDOSIS; HYPERTROPHIC CARDIOMYOPATHY; ATRIAL-FIBRILLATION; AL AMYLOIDOSIS; CONDUCTION SYSTEM; RISK; MANAGEMENT; DIAGNOSIS; OUTCOMES;
D O I
10.1016/j.mayocp.2018.08.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the prognostic impact of Holter findings in patients with light chain amyloidosis. Patients and Methods: We evaluated 239 patients in whom light chain amyloidosis was diagnosed from January 1, 2010, through December 31, 2015, who underwent 24-hour Holter monitoring. Results: Holter testing was done before stem cell transplant evaluation in 183 of the 239 patients (76.6%) and at diagnosis in 50 (20.9%). Holter findings were nonsustained ventricular tachycardia (NSVT) in 60 patients (25.1%), ventricular couplets in 103 (43.1)%, accelerated idioventricular rhythm in 32 (13.4%), and atrial fibrillation (AF) in 18 (7.5%). Overall survival (OS) at 3 and 6 months after Holter monitoring in patients with AF vs without AF was 78% (95% CI, 54%-91%) vs 96% (95% CI, 92%-98%) (P=.002) and 61% (95% CI, 38%-80%) vs 92% (95% CI, 87%-95%), (P<.001), respectively. In patients with and without NSVT, 3- and 6-month OS after Holter testing as 90% (95% CI, 80%-94%) vs 96% (95% CI, 91%-98%) (P=.12) and 77% (95% CI, 64%-85%) vs 94% (95% CI, 89%-97%) (P<.001), respectively. For patients with and without ventricular couplets, 3- and 6-month OS was 94% (95% CI, 88%-97%) vs 94% (95% CI, 89%-97%) (P=.98) and 84% (95% CI, 75%-89%) vs 94% (95% CI, 89%-97%) (P=.01), respectively. Atrial fibrillation (hazard ratio, 2.5; 95% CI, 1.2-5.0; P=.02) and NSVT (hazard ratio, 2.0; 95% CI, 1.1-3.5; P=.02) were independent predictors for OS after accounting for age and Mayo stage. For patients undergoing routine testing before stem cell transplant, AF (P=.002) and NSVT (P=.02) were associated with inferior OS at 6 months but did not retain statistical significance after adjusting for Mayo stage (P=.10 and P=.54, respectively). Conclusion: Atrial fibrillation and NSVT on 24-hour Holter monitoring are associated with inferior short-term OS outcomes but do not impact peritransplant mortality. (C) 2018 Mayo Foundation for Medical Education and Research
引用
收藏
页码:455 / 464
页数:10
相关论文
共 50 条
  • [1] Prognostic Value of Holter Monitoring in Light Chain Amyloidosis
    Sun, Yutong
    Zhao, Qinghao
    Liu, Yang
    Wen, Lei
    Dou, Xuelin
    Lu, Jin
    Liu, Jian
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (23)
  • [2] Prognostic Significance of Strain Doppler Imaging in Light-Chain Amyloidosis
    Koyama, Jun
    Falk, Rodney H.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2010, 3 (04) : 333 - 342
  • [3] Left atrial (dys)function in patients with light chain amyloidosis: A pathophysiological model with challenging prognostic significance
    Recupero, Antonino
    Di Bella, Gianluca
    Pugliatti, Pietro
    de Gregorio, Cesare
    [J]. JOURNAL OF CARDIOLOGY, 2018, 72 (3-4) : 367 - 368
  • [4] RENAL SURVIVAL PROGNOSTIC FACTORS IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS
    Stancu, Simona
    Calin, Cristiana
    Coriu, Daniel
    Badelita, Sorina
    Mircescu, Gabriel
    Stefan, Gabriel
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [5] Prognostic factors in light chain amyloidosis
    Javorniczky Nora Rebeka
    Bodo Imre
    Masszi Tamas
    Mikala Gabor
    [J]. ORVOSI HETILAP, 2015, 156 (39) : 1577 - 1584
  • [6] Left atrial (dys)function in patients with light chain amyloidosis: A pathophysiological model with challenging prognostic significance reply
    Mohty, Dania
    Petitalot, Vincent
    Magne, Julien
    Fadel, Bahaa M.
    Boulogne, Cyrille
    Rouabhia, Dounia
    El Hamel, Chahrazed
    Lavergne, David
    Damy, Thibaud
    Jaccard, Arnaud
    [J]. JOURNAL OF CARDIOLOGY, 2018, 72 (3-4) : 368 - 368
  • [7] Prognostic significance and impact of left-sided valvular thickening in patients with systemic light-chain amyloidosis
    Pradel, S.
    Mohty, D.
    Magne, J.
    Damy, T.
    Lavergne, D.
    Bridoux, F.
    Pibarot, P.
    Aboyans, V.
    Jaccard, A.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1084 - 1085
  • [8] Long-Term Prognostic Significance of Diastolic Wall Strain, and Heart Rate in Patients With Light-Chain Amyloidosis
    Koyama, Jun
    Kuwahara, Koichirou
    [J]. CIRCULATION, 2017, 136
  • [9] Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
    Kim, Darae
    Choi, Jin-Oh
    Kim, Kihyun
    Kim, Seok Jin
    Kim, Jung-Sun
    Jeon, Eun-Seok
    [J]. ESC HEART FAILURE, 2021, 8 (06): : 5594 - 5599
  • [10] Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
    Kim, Darae
    Choi, Jin-Oh
    Kim, Kihyun
    Kim, Seok Jin
    Kim, Jung-Sun
    Jeon, Eun-Seok
    [J]. ESC HEART FAILURE, 2022, 8 (06): : 5594 - 5599